New Super Pill for Heart Disease

Cost of treating heart disease expected to drop by 80 percent © Annie Austin

A new pill is to be tested in Spain that combines aspirin, statins, and ACE inhibitors – the three main therapies used to fight heart disease.

New Polypill for Heart Disease

Experts in the field of cardiology announced that a new pill that save millions suffering from heart disease. They did so at the World Congress of Cardiology in Barcelona, Spain on Monday, September 4th. The new pill – dubbed polypill – will contain aspirin, statins, and ACE inhibitors. According to the World Heart Federation, which is promoting the pill, the therapy will become available with in two years and will cost approximately one fifth of taking multiple pills for heart disease.

The World Congress of Heart Disease conference ran September 2-6 in Barcelona and attracted 25,000.

The new polypill is to be tested in Spain and will be exported to other countries within the next two years.

Close to 17 and a half million people die of heart disease each year.